Thrombopoietic status of patients on haemodialysis

Br J Haematol. 2016 Mar;172(6):954-7. doi: 10.1111/bjh.13918. Epub 2016 Feb 16.

Abstract

Thrombocytopenia is a potential dialysis-related treatment complication. Developments in bio-compatible dialyser membranes have decreased the occurrence of thrombocytopenia. We investigated whether thrombopoiesis is impaired in haemodialysis patients by measuring the thrombopoietin level and absolute immature platelet number (AIPN) in the blood of patients undergoing haemodialysis. Samples were collected from the dialysis tubing pre- and post- haemodialysis in a cohort of 45 well-characterized haemodialysis patients. Thrombopoietin levels and AIPN increased following haemodialysis, despite no change in platelet count. Observed increase in release of immature platelets from the bone marrow following haemodialysis indicates possible complement activation secondary to interaction between blood constituents and the dialysis membrane.

Keywords: IL1A (IL1α); absolute immature platelet number; haemodialysis; immature platelet fraction; thrombopoietin.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / therapy
  • Male
  • Middle Aged
  • Platelet Count
  • Platelet Function Tests / methods
  • Renal Dialysis / adverse effects*
  • Thrombocytopenia / blood
  • Thrombocytopenia / etiology*
  • Thrombopoiesis / physiology*
  • Thrombopoietin / blood

Substances

  • Thrombopoietin